> top > docs > PMC:7289100 > spans > 30167-31023 > annotations

PMC:7289100 / 30167-31023 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T381 148-166 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T382 335-348 Disease denotes viral disease http://purl.obolibrary.org/obo/MONDO_0005108
T383 468-484 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T384 544-562 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T385 645-654 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T386 830-847 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T238 203-208 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T128 785-790 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 468-484 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T192 0-356 Sentence denotes Since the breakout of the Covid-19 in late 2019 in China, many unresolved issues regarding both dealing with the fate of the preexisting autoimmune rheumatic diseases in patients who are affected by the virus including those under immunosuppressive and biologic therapy, as well as the impact of these therapies on the severity of the viral disease itself.
T193 357-677 Sentence denotes Early reports in the course of the pandemia suggested that based on the data recovered from other and previous viral infections, there would be an increased probability for patients with rheumatic diseases to acquire the Covid-19 disease or are they prone to an increased severity of the infection if they do acquire it.
T194 678-856 Sentence denotes On the contrary, however, early on, there was some evidence regarding the potential benefit of some of the drugs which have been used in the therapy of rheumatic disease [83,84].

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T424 26-34 SP_7 denotes Covid-19
T425 137-147 UBERON:0002405 denotes autoimmune
T426 203-208 NCBITaxon:10239 denotes virus
T427 231-248 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T428 335-340 NCBITaxon:10239 denotes viral
T429 468-473 NCBITaxon:10239 denotes viral
T430 578-586 SP_7 denotes Covid-19
T431 785-790 CHEBI:23888;CHEBI:23888 denotes drugs
T70814 26-34 SP_7 denotes Covid-19
T14206 137-147 UBERON:0002405 denotes autoimmune
T1510 203-208 NCBITaxon:10239 denotes virus
T87559 231-248 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T60635 335-340 NCBITaxon:10239 denotes viral
T2065 468-473 NCBITaxon:10239 denotes viral
T25480 578-586 SP_7 denotes Covid-19
T82970 785-790 CHEBI:23888;CHEBI:23888 denotes drugs

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1010 170-178 Species denotes patients Tax:9606
1011 530-538 Species denotes patients Tax:9606
1012 26-34 Disease denotes Covid-19 MESH:C000657245
1013 148-166 Disease denotes rheumatic diseases MESH:D012216
1014 335-348 Disease denotes viral disease MESH:D001102
1015 468-484 Disease denotes viral infections MESH:D001102
1016 544-562 Disease denotes rheumatic diseases MESH:D012216
1017 578-586 Disease denotes Covid-19 MESH:C000657245
1018 645-654 Disease denotes infection MESH:D007239
1019 830-847 Disease denotes rheumatic disease MESH:D012216